Cargando…
mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?()
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484506/ https://www.ncbi.nlm.nih.gov/pubmed/26137524 http://dx.doi.org/10.1016/j.ebiom.2014.12.011 |
_version_ | 1782378679176790016 |
---|---|
author | Kwiatkowski, David J. Wagle, Nikhil |
author_facet | Kwiatkowski, David J. Wagle, Nikhil |
author_sort | Kwiatkowski, David J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4484506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-44845062015-07-01 mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() Kwiatkowski, David J. Wagle, Nikhil EBioMedicine In Focus Elsevier 2014-12-26 /pmc/articles/PMC4484506/ /pubmed/26137524 http://dx.doi.org/10.1016/j.ebiom.2014.12.011 Text en © 2014 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | In Focus Kwiatkowski, David J. Wagle, Nikhil mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title | mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title_full | mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title_fullStr | mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title_full_unstemmed | mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title_short | mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?() |
title_sort | mtor inhibitors in cancer: what can we learn from exceptional responses?() |
topic | In Focus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484506/ https://www.ncbi.nlm.nih.gov/pubmed/26137524 http://dx.doi.org/10.1016/j.ebiom.2014.12.011 |
work_keys_str_mv | AT kwiatkowskidavidj mtorinhibitorsincancerwhatcanwelearnfromexceptionalresponses AT waglenikhil mtorinhibitorsincancerwhatcanwelearnfromexceptionalresponses |